Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 70 or older, or women aged 60 or older who have significant other health conditions or difficulties with daily activities (confirm with trial site for exact scoring thresholds)
- People with a confirmed diagnosis of stage III or IV ovarian cancer, primary peritoneal cancer, or fallopian tube cancer, verified by tissue or cell testing
- People whose care plan includes pelvic surgery, with or without chemotherapy given before the surgery
- People whose treatment plan has been reviewed and approved by a team of specialist doctors working together
- People with a life expectancy of more than 3 months
- People who have given written agreement to take part in the trial
- People who are covered by a health system where this requirement applies
Who may not be able to join:
- People who have another active cancer that may affect their outlook or prognosis
- People whose agreed treatment plan does not include surgery to reduce the tumour
- People who are unable to attend regular follow-up appointments for any reason, such as location, family situation, social circumstances, or psychological reasons
- People who are unable to understand and complete the study questionnaires
- People who are unable to follow the study procedures due to geographic, social, or psychological reasons
- People who are under legal guardianship or a similar supervised legal arrangement
- People who are currently detained or imprisoned
- People who are already taking part in another clinical trial involving an investigational drug
- People who have already been enrolled in this study previously
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 4.78.86.32.87
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Superiority for post-treatment complication grade≥3; Superiority of HRQOL on the dimensions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.